Mayo Clinic researchers have identified new scoring criteria allowing for the detection of treatable forms of rapidly progressive dementia (RPD) with reasonably high confidence during a patient’s first clinical visit. This scoring criteria may allow physicians to substantially reduce the time it takes to begin treatment. The findings are published in the Annals of Neurology.
Recent Posts
- Physical activity reverses the aging induced decline in angiogenic potential in the fast locomotory muscles of mice
- Scientists Just Discovered a Quick Way to Live a Longer, Healthier Life: Why You Should Follow the 15-2-Half Rule, Starting Today
- NASA awards National Stem Cell Foundation $3.1 million to continue studying the effects of microgravity on brain cells
- Healthspan Action Coalition and Kitalys Institute Propose Landmark Legislation to Promote Healthy Longevity
- Exposome has tenfold impact on mortality risk compared with genetics